Henry Schein (HSIC) : Pensionfund Sabic reduced its stake in Henry Schein by 10.48% during the most recent quarter end. The investment management company now holds a total of 9,400 shares of Henry Schein which is valued at $1.6 Million after selling 1,100 shares in Henry Schein according to a report filed by the company on Apr 4, 2016 with the SEC.Henry Schein makes up approximately 0.48% of Pensionfund Sabic’s portfolio.
Other Hedge Funds, Including ,
On the company’s financial health, Henry Schein reported $1.67 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Feb 10, 2016. Analyst had a consensus of $1.65. The company had revenue of $2850.91 million for the quarter, compared to analysts expectations of $2817.65 million. The company’s revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.56 EPS.
Many Wall Street Analysts have commented on Henry Schein. Henry Schein was Initiated by Credit Suisse to “Neutral” on Mar 16, 2016. Barrington Research Upgraded Henry Schein on Mar 1, 2016 to ” Outperform”, Price Target of the shares are set at $182.Company shares were Reiterated by Piper Jaffray on Feb 11, 2016 to “Neutral”, Firm has raised the Price Target to $ 159 from a previous price target of $158 .
Henry Schein closed down -1.39 points or -0.83% at $166.6 with 4,50,504 shares getting traded on Monday. Post opening the session at $168.96, the shares hit an intraday low of $166.11 and an intraday high of $169.18 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
Henry Schein Inc. provides health care products and services to office-based dental animal health and medical practitioners. The Company operates its business through two segments: health care distribution and technology and value-added services. The health care distribution segment distributes consumable products laboratory products equipment repair services branded and generic pharmaceuticals vaccines surgical products diagnostic tests infection-control products and vitamins among others. The Company’s global technology and value-added services segment provides software technology and other value-added services to health care practitioners. Its offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis e-services practice technology network and hardware services as well as continuing education services for practitioners.